Call Girls Hebbal Just Call 👗 7737669865 👗 Top Class Call Girl Service Bangalore
Etpl business model canvas workshop oct 2016
1. October 2016
2016 Business model canvas workshop
What do investors look for in a business plan?
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
2. 2
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
About the facilitator
• Wharton MBA
• JP Morgan – Vice President - IB Technology, Global
Markets Internet Marketing
• Parallax Capital Management – Co-founder and
MD - Venture Capital
• Extream Ventures – Co-founder and MD - S$20
million VC fund
• Expara – Founder and MD - IDM Ventures
Incubator, fund, advisory, training
• NUS – Adjunct Associate Professor, Business
School, Entrepreneurship
• Sasin – Visiting Professor, Venture Capital
3. 3
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Business model canvas workshop
12:00 PM Key elements for success - value proposition and innovation
1:30 PM Break
1:45 PM Key elements for success - competitive analysis and strategy
3:15 PM Break
3:30 PM Fund raising and financial plan
5:30 PM End
4. 4
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
From Idea to Investment
• Key elements for success
• Financial plan and fundraising
5. 5
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Key elements for success
• Develop an innovative product – Innovation
• Solve a problem for customers – Value proposition
• Identify your customers – Market identification and analysis
• Reach your customers – Marketing strategy
• Compete when others enter - Sustainable competitive advantage
• Make money – Business model and financial plan
• Team – A team or B team
6. 6
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Problem Solution
Key
Metrics
Cost drivers Revenue model
Value
proposition
and
innovation
Sustainable
competitive
advantage
Channels
Customer
segments
Market size
Customer
archetype
High concept
Existing
solutions
Top 1-3 customer
problems
How are these
problems solved
today?
Your solutions to
customer
problems
Key numbers that
tell if you are
succeeding
What is innovative
about your
solution? Why are
you better than
existing solutions?
One sentence
that says it all
How will you
create barriers to
entry for
followers?
How will you get
your product to
customers?
Who are your
target
customers?
How big is your
market and how
fast is it growing?
Characteristics of
your key
customers
How do you
generate
revenue?
What are your
key cost drivers?
Expara Business Model Canvas
7. 7
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Why is biotech unlike any other?
• Lean startup does not apply to biotech
• Can’t develop new drug, biologic or medical device, market it
immediately to the public, and later make small adjustments
• Most highly regulated industry
• Development to fundraising can take three to 10 years
• For companies that succeed, the revenues and profits far
exceeds other sectors
• Immensely gratifying
• You have to sell the science
8. 8
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Key differences between tech and biomed plans
Value of IP
Regulatory approval
Marketing strategy
Time to market
Business model
Valuation model
Exit strategy
Risk
Scale of financing
Factors
Bio-tech Med-tech
Product Tool
How different is it from tech plans?
Low Somewhat High
9. 9
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Questions to answer
• Innovation
• Value proposition
• Market identification and analysis
• Marketing strategy
• Sustainable competitive advantage
• Financials
10. 10
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Don’t go too early or too late
Measure of
performance
Measure of effort invested
The technology adoption S curve
11. 11
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Value proposition and innovation
1. What is the painful problem you are solving for customers? How
painful is that problem (cancer vs flu)?
2. What is your product and what is innovative about it?
3. What are the shortfalls of the current solutions?
4. How do you solve this problem and can you quantify your benefit?
5. How does your innovation enable you to accomplish this?
13. 13
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Disruptive business model or disruptive tech
• Diamond is the first mover in
portable MP3 in 1998
• Apple enters in 2003 and
captures 90% of the market
• Business model innovation –
hardware + software + service
14. 14
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Business model innovation: Gillette to Google
• Gillette – razor and blade
• Southwest Airlines – budget airlines
• Dell Computer – mass customization
• Charles Schwab – on-line broker
• Amazon – ecommerce
• eBay – peer to peer marketplace
• Google – search-based advertising
15. 15
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Market identification and analysis
1. Who is your customer?
2. How big is your market and how fast is it growing?
– Top-down approach
– Bottom-up approach
3. What trends in your market are favourable for you?
– Technological, social, demographic, regulatory
4. Who are your direct and indirect competitors?
5. How is your market segmented?
16. 16
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Top-down revenue projections
Total addressable market
Target market
Target segment
Market share
18. 18
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Marketing strategy
1. How is your product differentiated from your competitors’ product?
Use a comparison matrix to illustrate.
2. What is your position in the market? Use a positioning map or
Blue Ocean Strategy canvas to illustrate
3. What are your price, place, product, promotion and initial sales
plans
4. What is your tagline?
20. 20
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Positioning map
Portability
Value
Competitor 2
Your company
Competitor 1
Competitor 3
Competitor 4
21. 21
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Blue Ocean strategy canvas
www.blueoceanstrategy.com
23. 23
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Sales and distribution
• Great sales and distribution vs great product
• Best sales is hidden
• Products don’t sell themselves
24. 24
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Metrics for effective distribution
• CLV: total net profit earned over the course of relationship with
customer
• CAC: cost to acquire a new customer
• CLV>CAC
25. 25
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Sustainable competitive advantage
1. How will you compete with small followers?
2. How will you compete with large companies who decide to move
into your space?
3. What is your IP strategy?
4. What are your competitive strategies to create barriers to entry?
26. 26
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
First-mover advantages and disadvantages
• Reputation
• Preempting positioning
• Switching costs/Lock-in/Network effects
• Unique channel access
• Move down learning curve
• Favorable access to inputs
• Definition of standards
• Institutional barriers – IP protection
Advantages
• Pioneering costs
• Demand uncertainty
• Changes in buyer needs
• Specificity of investments
to early generations
• Technological
discontinuities
• Low-cost imitation
Disadvantages
27. 27
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Established company strengths and weaknesses
• Learning curve
• Reputation effect
• Cash flow
• Economies of scale
• Complementary
assets
Advantages
• Difficult to innovate
• They need to satisfy existing customers,
partners and supply chain
• Existing organizational structure is appropriate
to current tasks
• Risk aversion
Weaknesses
28. 28
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Opportunities that favor new firms
• Existing firms frozen in the headlights
• Disruptive technologies and business models
• Uncertainty: existing firms’ advantages in market research are
neutralized; risk propensity
• Technologies: Discrete versus systemic technologies, based on
human capital, general purpose rather than specific
• Bad customers: Enter market that is unattractive to existing
competitors due to established cost structure
29. 29
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Regulatory approval for drug development
Drug
discovery
and pre-
clinical
Phase I Phase II Phase III NDA/BLA
3.5 years 1 year 2 years 3 years 1-2 years
Success rates: 30% 70% 70% 80%
Financing required: $250K to
$1.5M
$2M to $20M $20M to
$100M
30. 30
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
From Idea to Investment
• Key elements for success
• Financial plan and fundraising
31. 31
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
In the financial section of the business plan
1. Business model
– Revenue model
– Cost structure
2. Financial projections
3. Valuation
4. Funding required and equity offered
5. Use of Proceeds
6. Exit Strategy and ROI
32. 32
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Elements of a business model
• Revenue models
• Cost structures
33. 33
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Differences in business models
Biotech
Tool platform
Hybrid
Product - virtual
Med tech
Similar to tech
Revenue drivers and cost
drivers
34. 34
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Biotech- product business model
Product
One- product
Platform
Drug discovery Licensing
Commercialization
In-house
Partner
Pricing & positioningAlternative
GenericsDiscount
Premium
Research &
manufacturing
In-house
Virtual
35. 35
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Biotech business models
Advantages Disadvantages
Tool
platform
Generate revenues early Lower returns
No need for regulatory
approval
Hybrid
(best of
both
worlds?
Balance of risk and
return
Spread of resources
thinly
Generate revenues early Lack of strategic focus
Product High returns Scale of financing
No revenue generation High risk
Time to
commercialization/time
to exit?
36. 36
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Differences in valuation models
Biotech
Product: Simulation
(incorporate DCF)/real
option valuation
Hybrid: DCF and
simulation (incorporate
DCF)/real option
valuation)
Tool Platform: Simulation
(incorporate DCF)/real
option valuation
Med tech
Similar to tech
valuation models
Discounted Cash flow
(DCF)
37. 37
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Calculate investor’s ROI including dilution
38. 38
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Stages and sources of funds
Founder’s
Capital
Seed/
Angel
Series
A, B, C
Mezzanine Pre-Exit Exit
VC hurdle rates 60-100% 40-60% 20%
OM
F,F&F
Incubators
corporations
government
Customers, suppliers,
strategic partners
VCs, Banks for VC loans
R&D Establishment GTM/Rollout Accelerated Expansion Maturity
Enablement growth
39. 39
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Value inflection points in biotech- product
Early
– Clearly articulated strategy
– Team
– The key IP
– Initial proof-of-concept
Later
– IND-enabling studies
– Clinical safety
– Clinical proof-of-concept
– Phase 3
– Market validation
40. 40
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Differences in exit strategy for biotech - product
• Biotech companies can exit via IPO without revenues
• Tesaro, Kythera and Intercept are companies that hit the public
market during their phase III program in 2012
• Tetraphase also exited via a $75 million IPO in 2013
42. 42
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Key elements of a term sheet
• Board of directors
• Protective provisions
• Drag-along agreement
• Conversion
Control
• Price-per-share
• Valuation
• Amount of financing
• Liquidation preference
• Vesting
• Options pool
• Anti-dilution
• Pay-to-play
Economics
43. 43
6XXXX
Douglas Abrams Workshop organized by ETPL’ Investment and Spin-off Management Division
Contact us
• Douglas Abrams
• Expara Pte. Ltd.
• dka@expara.com
• www.expara.com
• 65-6323-3084, 65-9780-5381 (hp)
• Block 71 Ayer Rajah Crescent, #02-10/11 Singapore 139951